Govt starts counsel process for new science, innovation and advancement strategy Kumar Jeetendra | June 3, 2020 The administration has started an interview procedure for detailing of another national Science, Technology and Innovation Policy (STIP 2020), an announcement said. The Office of the Principal Scientific Adviser to the Government of India (Office of PSA) and the Department of Science and Technology (DST) have together started a decentralized, base up and comprehensive procedure …
Immunization group plans advance market understanding for COVID-19 antibodies Kumar Jeetendra | June 4, 2020 The GAVI immunizations coalition is to dispatch an Advance Market Commitment (AMC) for future COVID-19 antibodies which it says will help secure access to the new shots for less fortunate nations. The AMC component ought to give motivating forces to antibody makers to put resources into huge scope creation limit even as they grow new …
Coronavirus spread from individuals without manifestations is uncommon, says WHO Kumar Jeetendra | June 9, 2020 The World Health Organization says it despite everything accepts the spread of the coronavirus from individuals without manifestations is “uncommon,” regardless of alerts from various specialists worldwide that such transmission is increasingly visit and likely clarifies why the pandemic has been so difficult to contain. Maria Van Kerkhove, WHO’s’ specialized lead on COVID-19 said at …
IIT-KGP specialists create AI-based framework to follow social distancing Kumar Jeetendra | June 13, 2020 A gathering of specialists at IIT-Kharagpur has built up a digital physical framework dependent on computerized reasoning for checking social removing in broad daylight puts, an authority said on Saturday. The group, under the authority of teacher Debashish Chakravarty and educator Aditya Bandopadhyay, has designed a minimal effort gadget which can recognize the hole between …
Researchers taking a gander at tuberculosis, polio immunizations to avert coronavirus: report Kumar Jeetendra | June 14, 2020 Specialists in the US are taking a gander at the chance of utilizing tuberculosis and polio immunizations in giving insurance from the savage coronavirus, as indicated by a media report. Tests are in progress to check whether the tuberculosis immunization can slow the novel coronavirus, The Washington Post provided details regarding Thursday. “This is the …
Hetero, Cipla get gesture to make, market antiviral medication remdesivir Kumar Jeetendra | June 21, 2020 India’s Drug Regulator on June 20 allowed to Hetero and Cipla to produce and market antiviral medication remdesivir for “confined crisis use” on hospitalized COVID-19 patients, official sources said. This comes a day after the Drug Controller General of India (DCGI), thinking about the crisis and neglected requirement for medications considering the coronavirus episode, allowed …